The Viewpoint

Bio-Techne sees the potential for some of its most exciting and lucrative contributions to science and precision medicine as the industry matures. (Anthony Souffle/Minneapolis Star Tribune/TNS)

Biotech firm carves a large niche in tools for research

March 16, 2017

MINNEAPOLIS — More than 600,000 times, researchers have cited Bio-Techne Corp. in academic papers as a manufacturer of tools that helped in their search for new tests and treatments. The company,...

Load More Stories

Comments (0)

All The Viewpoint Picks Reader Picks Sort: Newest
Activate Search
cancer immunotherapy